Cemag Invest
Paris family office founded in 2016, investing in health and technology companies; backers of Orikio, Wandercraft, Diabeloop, Avicenna.ai and Aryballe.
USEFUL FOR Co-investors
Family & background
- HEADQUARTERS
- Paris, France
- FOUNDED
- 2016
Investment approach
- SECTORS
- HealthTechDeep Tech
- GEOGRAPHY
- France
- ROUTES
- Companies (own capital)
- STRATEGIES
- Direct investmentsVenture capital
- LATEST DEAL
- Orikio (Series A) · Apr 2023
Overview
Cemag Invest is a Paris company (LEI 9695003J7D3WV9RQU187, SIREN 818807422) created in February 2016. It describes itself as a family office dedicated to health and technology, focusing on simple but disruptive solutions that add value for patients. It has invested in Wandercraft, Diabeloop, Avicenna.ai and Aryballe Technologies, took a stake in Orikio (ex OSO-AI) in 2020 and joined its EUR 10 million Series A in April 2023. Its president is Catherine Dunand.
Investment thesis
A family office dedicated to health and technology, paying particular attention to adding value to patients and focusing on simple but disruptive technological solutions.
Holdings & investments (5)
- HealthTech · since 2020
- WandercraftHealthTech
- DiabeloopHealthTech
- Avicenna.aiHealthTech
- Aryballe TechnologiesDeep Tech
People
- Catherine DunandPresident · source
- Arnaud de la TourManaging Director · source
Frequently asked questions
Cemag Invest is a single family office based in Paris, France, founded in 2016.
Cemag Invest invests its own capital into companies. Its stated asset mix includes direct investments and venture capital.
Cemag Invest invests in HealthTech and Deep Tech.
Key people at Cemag Invest include Catherine Dunand (President) and Arnaud de la Tour (Managing Director).
Cemag Invest's holdings and investments include Orikio (ex OSO-AI), Wandercraft, Diabeloop, Avicenna.ai and Aryballe Technologies.
The most recent publicly reported investment by Cemag Invest is Orikio (Series A), announced in Apr 2023.